Early Access Program
Trailblazing Clinicians
We partner with select proactive and longevity medicine physicians
We help physicians develop senescence expertise and understand how their interventions impact aging trajectory in individual clients. The early access program requires enrollment into our IRB-approved clinical study.
Intervention Testing
We partner with physicians to explore the impact of specific interventions on cellular senescence and aging
We guide design, analysis, and publication of studies on specific interventions with the potential to improve cellular senescence and aging trajectory.
Level Up
Decisions
Reveal individual aging trajectories, optimize interventions, and monitor progress
Distinguish
Your Practice
Measure fundamental biological mechanisms of aging supported by cutting-edge science
Accelerate
Discovery
Discover how to optimize the risk:benefit ratio of longevity interventions